Using genome-wide analysis, independent studies recently reported that the S34F/Y mutations of U2AF1 alters 3’ss selection and enhances aberrant exon inclusion (Figure 2B), leading to hematological malignancies, including MDS [176,177]. The gene discussed is U2AF1; the disease is myelodysplastic syndrome.